1. Home
  2. WLDN vs NNNN Comparison

WLDN vs NNNN Comparison

Compare WLDN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$91.81

Market Cap

1.2B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$33.59

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
NNNN
Founded
1964
2021
Country
United States
Germany
Employees
N/A
27
Industry
Military/Government/Technical
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
WLDN
NNNN
Price
$91.81
$33.59
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$114.50
N/A
AVG Volume (30 Days)
450.6K
14.9K
Earning Date
05-07-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
120.89
N/A
EPS
0.55
N/A
Revenue
$273,352,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.05
N/A
P/E Ratio
$167.37
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$53.44
$7.76
52 Week High
$137.00
$55.65

Technical Indicators

Market Signals
Indicator
WLDN
NNNN
Relative Strength Index (RSI) 57.69 66.49
Support Level $86.37 $26.31
Resistance Level $98.22 $44.06
Average True Range (ATR) 4.99 3.05
MACD 0.26 0.66
Stochastic Oscillator 51.00 90.43

Price Performance

Historical Comparison
WLDN
NNNN

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: